Drug recall · January 11, 2023
Acyclovir Sodium Injection 1 recall
Why: Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20
- Lots / codes
Lot # AC22004, Expiry: 08/2023
- Quantity
- 45,250 vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 28, 2022 · Voluntary: Firm initiated
- Classified
- January 3, 2023
- Reported
- January 11, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acyclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.